Cordance Medical’s NeuroAccess Receives FDA Breakthrough Device Designation     The FDA has granted NeuroAccess from Cordance Medical, a medical device company focused on opening the Blood-Brain Barrier (BBB) to facilitate liquid biopsy, Breakthrough Device Designation. The NeuroAccess device is indicated for adult patients (aged 22 and above) who have received a known or highly suspected …

Cordance Medical’s NeuroAccess Receives FDA Breakthrough Device Designation Read More »